Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
E.A.M. reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech, and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; institutional research support from Roche/Genentech (via SU2C grant) and Gilead; research funding from Susan Komen for the Cure, for which she serves as a Scientific Advisor; and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. T.A.K. reports speaker honoraria and an advisory board role for Exact Sciences and is on the global advisory board of Besins Healthcare. All other authors report no disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This work was accepted for oral presentation at the American Society of Breast Surgeons Annual Meeting on April 28, 2023, in Boston, MA.
Rights and permissions
About this article
Cite this article
Pride, R.M., Glass, C.C., Nakhlis, F. et al. ASO Visual Abstract: Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy. Ann Surg Oncol 30, 5988–5989 (2023). https://doi.org/10.1245/s10434-023-14000-6
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14000-6